IVC Evidensia
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
IVC Evidensia - overview
Established
2017
Location
-, -, UK
Primary Industry
Healthcare
About
IVC Evidensia, based in the UK, operates a vast network in the veterinary care sector, providing essential services to ensure animal health and well-being through a team of skilled professionals. Founded in 2017, IVC Evidensia specializes in veterinary services across approximately 2,500 locations in 20 countries, including the UK, France, Germany, and Sweden. The company has engaged in 3 deals, with the most recent being on March 5, 2024, during which they secured a Secondary Buyout of EUR 3,500. 00 mn led by Silver Lake, alongside investors EQT and Nestlé S.
A. Olof Skarman is noted as a founder, contributing his experience to the company’s growth. The company has raised a total of EUR 350. 00 mn throughout its funding rounds.
IVC Evidensia is a prominent player in the veterinary care sector, offering a comprehensive range of services aimed at enhancing the health and well-being of animals. The company’s core offerings include veterinary consultations, diagnostic services, surgical procedures, and specialized care provided by a team of experienced veterinarians, veterinary nurses, and specialists. These services address various animal health issues, including preventive care, emergency treatment, and critical care, ensuring healthy animals and satisfied pet owners. IVC Evidensia generates revenue primarily through fee-for-service transactions with pet owners and partnerships with veterinary practices.
This includes income from routine check-ups, surgeries, and emergency care, with clients typically paying at the point of service. Revenue is supported by collaborations with various veterinarians and clinics, emphasizing high-quality veterinary care backed by a skilled network of professionals. Looking ahead, IVC Evidensia plans to leverage its recent funding secured on March 5, 2024, which includes a EUR 2 million senior term loan from CIC Private Debt, to support the expansion of its veterinary services into new geographic markets. This will enhance its operational capabilities and service offerings across its existing network.
Specific markets targeted for this expansion have not been disclosed.
Current Investors
EQT, Silver Lake, Nestlé S.A.
Primary Industry
Healthcare
Sub Industries
Clinics/Outpatient Services, Hospitals
Website
www.ivcevidensia.com
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
IVC Evidensia - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Vetarrábida – Clínica Veterinária, Lda | - | ||||||||
| Add-on | Completed | Lecznica Weterynaryjna Zwierzyniec II S.C. | - | ||||||||
| Private Debt | Completed | IVC Evidensia | - | ||||||||
| Add-on | Completed | Greven Small Animal Center | - | ||||||||
| Add-on | Completed | Tierärzte IVC Evidensia GmbH | - |
Displaying 1 - 5 of 13

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.